色噜噜人体337p人体 I 超碰97观看 I 91久久香蕉国产日韩欧美9色 I 色婷婷我要去我去也 I 日本午夜a I 国产av高清怡春院 I 桃色精品 I 91香蕉国产 I 另类小说第一页 I 日操夜夜操 I 久久性色 I 日韩欧在线 I 国产深夜在线观看 I 免费的av I 18在线观看视频 I 他也色在线视频 I 亚洲熟女中文字幕男人总站 I 亚洲国产综合精品中文第一 I 人妻丰满熟av无码区hd I 新黄色网址 I 国产精品真实灌醉女在线播放 I 欧美巨大荫蒂茸毛毛人妖 I 国产一区欧美 I 欧洲亚洲1卡二卡三卡2021 I 国产亚洲欧美在线观看三区 I 97精品无人区乱码在线观看 I 欧美妇人 I 96精品在线视频 I 国产人免费视频在线观看 I 91麻豆国产福利在线观看

雅思閱讀模擬試題參考

時間:2021-06-10 19:14:49 試題 我要投稿

雅思閱讀模擬試題參考

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

雅思閱讀模擬試題參考

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock.

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

  Under pressure

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap.

  Going up

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.

  (613 words nature)

  Questions 1-7

  This passage has 7 paragraphs 1-7.

  Choose the correct heading for each paragraph from the list of headings below.

  Write the correct number i-ix in boxes 1-7 on your answer sheet.

  List of Headings

  i. How does torcetrapib work?

  ii. Contradictory result prior to the current trial

  iii. One failure may possibly bring about future success

  iv. The failure doesn’t lead to total loss of confidence

  v. It is the right route to follow

  vi. Why it’s stopped

  vii. They may combine and theoretically produce ideal result

  viii. What’s wrong with the drug

  ix. It might be wrong at the first place

  Example answer

  Paragraph 1 iv

  1. Paragraph 2

  2. Paragraph 3

  3. Paragraph 4

  4. Paragraph 5

  5. Paragraph 6

  6. Paragraph 7

  Questions 7-13

  Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。

  Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.

  NB You may use any letter more than once.

  7.It has been administered to over 10,000 subjects in a clinical trial.

  8.It could help rid human body of cholesterol.

  9.Researchers are yet to find more about it.

  10. It was used to reduce the level of cholesterol.

  11. According to Kashyap, it might lead to unwanted result if it’s blocked.

  12. It produced contradictory results in different trials.

  13. It could inhibit LDLs.

  List of choices

  A. Torcetrapic

  B. HDLS

  C. Statin

  D. CETP

  (by Zhou Hong)

  Suggested Answers and Explanations

  1. vi

  2. ii

  3. vii 本段介紹了torcetrapib和statin的治病原理,但是同時短語in contrast與之前第二段后半段的內容呼應,暗示了這兩種藥在理論上能相輔相成,是理想的搭配。第一個選項無法涵蓋整段意義,故選擇i是錯誤的。

  4. iii 本段分析了可能導致torcetrapibl臨床試驗失敗的原因,后半段指出如果以上推測正確,那么未來的藥物可借鑒這個試驗,設法避免torcetrapib的缺陷,研制出有效的'藥物。viii選項無法涵蓋后半段的意思。

  5. ix 見首句。

  6. v

  7. A 見第二段。題目中administer一詞意為用藥,subject一詞為實驗對象之意。

  8. B 見第四段… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.即HDLs的作用最終是將 choleserol清除出人體:… for removal from the body。

  9. B 見第四段But HDLs are complex and not entirely understood.

  10. C 見第二段… plus a cholesterol-lowering statin,即statin是可以降低cholesterol的。

  11. D 見第六段 So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

  12. A 見第三段。

  13. C 見第四段Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins.

【雅思閱讀模擬試題參考】相關文章:

雅思歷年閱讀模擬試題04-01

雅思閱讀模擬練習試題及答案11-26

雅思模擬閱讀習題06-14

雅思聽力模擬試題練習03-19

科學模擬試題參考06-11

模擬試題及答案參考06-13

雅思閱讀模擬練習題06-14

雅思閱讀經典模擬題06-13

關于雅思閱讀模擬習題及答案12-27

主站蜘蛛池模板: 国产一区免费视频 | 精品国产拍国产天天人 | 国产精品激情欧美可乐视频 | 色屁屁草草影院ccyycom | 欧美综合乱图图区乱图图区 | 国产自产高清不卡 | 国产对白精品刺激二区国语 | 免费高清欧美一区二区三区 | 午夜亚洲成人 | 免费国产拍久久受拍久久 | 久久久精品综合 | 99久久久国产精品 | 操一操免费视频 | 国产一级一片免费播放 | 玩弄丰满熟妇xxxxx性视频 | 国产亚洲欧美另类一区二区三区 | 欧美亚洲国产视频 | 伊人国产在线观看 | 日日操天天爽 | www.天天色 | 黄色免费视频大全 | 欧美成aⅴ人高清免费观看 成人h视频 | 免费无码高潮流白浆视频 | 五月天久久久久久九一站片 | 日韩三级毛片在线观看 | 日本中文字幕网 | 国产精品无码v在线观看 | 亚洲天堂中文字幕在线观看 | 日本在线视频中文字幕 | 18禁裸体动漫美女无遮挡网站 | 中文无码一区二区视频在线播放量 | 国产一区二区无码专区 | 毛片基地免费 | 国产精品点击进入在线影院高清 | 小早川怜子久久精品中文字幕 | 狠狠鲁狠狠干 | 五月天激情婷婷婷久久 | 精品国产精品三级精品av网址 | 狠狠色噜噜狠狠狠狠777米奇 | 三级毛片黄色 | 91福利视频网| 久久精品国自产拍天天拍最新章节 | 一级黄色片国产 | 99精产国品一二三产区在线 | 激情视频日韩 | 大量国自拍情侣 | 91视频区| 成人av一区二区兰花在线播放 | 蜜桃传媒一区二区 | 欧美午夜久久 | 激情在线一区 | 伊人伊成久久人综合网小说 | 91亚洲狠狠婷婷综合久久久 | 中文字幕亚洲欧洲 | 性人久久精品 | 国色精品卡一卡2卡3卡4卡在线 | 曰韩人妻无码一区二区三区综合部 | 激情av一区二区 | 爱啪啪av网 | 国产午夜成人av在线播放 | 国产一级a毛片视频爆浆 | 免费无遮挡男女交性视频 | 成年人视频在线观看网站 | 免费av一区 | 国产无遮挡又黄又爽免费视频 | 伊人影院视频 | 亚洲国产制服丝袜无码av | 欧美伊人精品成人久久综合97 | 中文 欧美 日韩 | 91白丝在线观看 | 天天狠天天透天干天天 | 国产一级做a爰片久久 | 中文日产幕无线码6区收藏 性中国古装v | 成熟丰满少妇激情xxxx | 激情偷拍av | 九色porny视频 | 99国产精品久久久久久久日本竹 | 一区二区免费看视频 | 国产视频久 | 国产猛烈高潮尖叫视频免费 | 青草影院内射中出高潮-百度 | 国产成人无码精品xxxx | 国产精品一区二区高清在线 | 亚洲一二三av | 黑人3p波多野结衣在线观看 | 中文字幕一区二区三区人妻少妇 | 在线看岛国av | 国产精品一区二区免费视频 | 视频日韩 | 99久久精品免费看国产一区二区三区 | 精品亚洲成人 | 欧美色资源 | www.99视频 | 国产色吧| 国内自拍视频在线播放 | 久草a在线| 色欲天天婬色婬香综合网完整 | 张津瑜警花国产精品一区 | 天天干,夜夜爽 |